These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6712858)

  • 21. Changes in blood pressure, fluid volumes and glomerular filtration rate during long-term treatment with prizidilol, an antihypertensive drug with combined vasodilatator and beta-adrenoceptor blocking actions.
    Andersen GS; Hartling OJ; Hein HO; Leth A
    Dan Med Bull; 1985 Oct; 32(5):280-3. PubMed ID: 2865088
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of prizidilol (SKF 92657) on blood pressure, haemodynamics, sympathetic nervous system activity and plasma volume in essential hypertension.
    Fariello R; Alicandri CL; Agabiti-Rosei E; Romanelli G; Castellano M; Beschi M; Platto L; Di Priolo SL; Muiesan G
    Clin Sci (Lond); 1981 Dec; 61 Suppl 7():465s-468s. PubMed ID: 7318352
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antihypertensive and renal effects of tertatolol, a new beta-blocking agent, in hypertensive patients.
    Salvetti A; Leonetti G; Bernini GP; Rupoli L; Lucarini AR; Sangiorgio P; Mauro M; Di Stratis P; Zanchetti A
    Am J Nephrol; 1986; 6 Suppl 2():45-9. PubMed ID: 2879473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An assessment of beta-adrenoceptor blockade in man by prizidilol hydrochloride.
    Pitcher DW; Curry PV; Trounce JR
    Br J Clin Pharmacol; 1982 May; 13(5):711-6. PubMed ID: 6123343
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospective measurement of glomerular filtration rate and effective renal plasma flow during treatment of malignant essential hypertension.
    Ghose RR
    Postgrad Med J; 1984 Oct; 60(708):662-4. PubMed ID: 6494086
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antihypertensive effect of prizidilol.
    Andrén L; Hansson L; Svensson A
    J Cardiovasc Pharmacol; 1983; 5(5):898-900. PubMed ID: 6195483
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enalapril in essential hypertension.
    Herrera-Acosta J; Pérez-Grovas H; Fernández M; Arriaga J
    Drugs; 1985; 30 Suppl 1():35-46. PubMed ID: 2994986
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antihypertensive effect of a non-selective (propranolol) and a cardioselective (metoprolol) beta-adrenoceptor blocking agent at rest and during exercise.
    Clausen N; Damsgaard T; Mellemgaard K
    Br J Clin Pharmacol; 1979 Apr; 7(4):379-83. PubMed ID: 375959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Changes in renal arterial flow during the treatment of essential arterial hypertension; prazosin in comparison with propranolol].
    O'Connor DT; Preston RA; Sasso EH
    Cardiology; 1980; 66 Suppl 2():69-73. PubMed ID: 7285032
    [No Abstract]   [Full Text] [Related]  

  • 30. Haemodynamic and hormonal effects of cilazapril in comparison with propranolol in healthy subjects and in hypertensive patients.
    Kleinbloesem CH; Erb K; Essig J; Breithaupt K; Belz GG
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):309S-315S. PubMed ID: 2527544
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative effects of antihypertensive therapy with guanabenz and propranolol on renal vascular resistance and left ventricular mass.
    Mosley C; O'Connor DT; Taylor A; Slutsky RA; Cervenka J
    J Cardiovasc Pharmacol; 1984; 6 Suppl 5():S757-61. PubMed ID: 6084120
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renal perfusion changes during treatment of essential hypertension: prazosin versus propranolol.
    O'Connor DT; Preston RA; Sasso EH
    J Cardiovasc Pharmacol; 1979; 1(6 Suppl):S38-42. PubMed ID: 94638
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effects of manidipine hydrochloride on renal function in renal parenchymal hypertensive patients].
    Ohashi H; Oda H; Matsuno Y; Watanabe S; Kotoo Y
    Nihon Jinzo Gakkai Shi; 1994 Mar; 36(3):239-45. PubMed ID: 8196220
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of long-term losartan and L-arginine treatment on haemodynamics, glomerular filtration, and SOD activity in spontaneously hypertensive rats.
    Miloradović Z; Jovović D; Mihailović-Stanojević N; Milanović JG; Milanović S
    Can J Physiol Pharmacol; 2008 Apr; 86(4):210-4. PubMed ID: 18418431
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renal hemodynamic effects of tertatolol compared with those of propranolol in the conscious dog.
    Laubie M; Prost JF; Rochat C
    Am J Nephrol; 1986; 6 Suppl 2():20-4. PubMed ID: 2879468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nephroprotection by antihypertensive agents.
    Schmieder RE
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S55-64. PubMed ID: 7898095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of cadralazine on systemic blood pressure, renal function and plasma renin activity in anesthetized dogs.
    Yukimura T; Miura K; Tanaka M; Higashio T; Sakaguchi S; Kuroda K; Yamamoto K
    Arzneimittelforschung; 1988 Jan; 38(1):25-8. PubMed ID: 3284531
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beta-blockers and the kidney.
    Epstein M; Oster JR
    Miner Electrolyte Metab; 1982 Nov; 8(5):237-54. PubMed ID: 6132329
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of lisinopril on cardiorespiratory, neuroendocrine, and renal function in patients with asymptomatic left ventricular dysfunction.
    Cleland JG; Shah D; Krikler S; Dritsas A; Nihoyannopoulos P; Frost G; Oakley CM
    Br Heart J; 1993 Jun; 69(6):512-5. PubMed ID: 8393685
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antihypertensive effect of propranolol at rest and during exercise.
    Leenen FH; Boer P; Dorhout Mees EJ
    Br J Clin Pharmacol; 1983 Mar; 15(3):361-5. PubMed ID: 6342641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.